Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer

INTRODUCTION: Utilization of docetaxel in patients with metastatic castration resistant prostate cancer (mCRPC) remains low despite its demonstrated survival benefit. In a population-based cohort, we sought to determine whether the introduction of docetaxel has improved overall survival (OS). METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zielinski, Robert R., Azad, Arun A., Chi, Kim N., Tyldesely, Scott
Formato: Artigo
Idioma:Inglês
Publicado em: Canadian Medical Association 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137017/
https://ncbi.nlm.nih.gov/pubmed/25210555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados